JUN 10, 2021 9:05 AM PDT

Micro- and Nano-Vesicular (CMP) Liquid Biopsies for Pregnancies: A Non-Invasive Window Into the Womb

Speaker

Abstract

The concentration of Circulating microparticles (CMPs) increases more than two-fold during pregnancy and offers a minimally invasive means to “biopsy” maternal-fetal tissues. CMPs obtained at the end of the first trimester, are a good source of protein biomarkers to detect physiologic changes systemically such that the risk of spontaneous preterm delivery (sPTB) at <35 weeks can be stratified.

Extended clinical validations of the sPTB biomarkers, have demonstrated that CMP-associated proteins, obtained at 12 weeks’ gestation, may predict the overall risk of early preeclampsia and indicate distinct subtypes of pathophysiology and clinical morbidity. The approach is being extended to a placental disease called placenta accreta, a life-threatening condition wherein the placenta grows too deeply into the uterine wall and does not deliver readily during birth. The early detection of a host of diseases and complications of pregnancy, using vesicular content derived from maternal and fetal compartments and, systemically, from a broad range of tissues and pathophysiological processes, could lead to better management and early interventions that improve birth outcomes and save lives.


Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
SEP 16, 2021 8:00 AM PDT
C.E. CREDITS
SEP 16, 2021 8:00 AM PDT
Date: September 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. T...
DEC 07, 2021 10:00 AM PST
C.E. CREDITS
DEC 07, 2021 10:00 AM PST
Date: December 07, 2021 Time: 10:00am (PST) The RNAscope™ technology allows high sensitivity and spatial resolution providing pivotal single-cell information to gain better insights in...
JUN 24, 2021 8:00 AM PDT
C.E. CREDITS
JUN 24, 2021 8:00 AM PDT
Date: June 24, 2021 Time: 8:00am (PDT), 11:00am (EDT) Cardiovascular disease is a leading health problem, affecting almost 30% of individuals in the developed world, and comprises a wide ran...
Loading Comments...
Show Resources